Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

BACKGROUND: Patients with renal impairment receiving classical anticoagulation for venous thromboembolism (VTE) are at increased risk of bleeding and possibly pulmonary embolism. We examined the efficacy and safety of oral rivaroxaban in patients with VTE with and without renal impairment. METHODS:...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Thromb J
मुख्य लेखकों: Bauersachs, Rupert M, Lensing, Anthonie WA, Prins, Martin H, Kubitza, Dagmar, Pap, Ákos F, Decousus, Hervé, Beyer-Westendorf, Jan, Prandoni, Paolo
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2014
विषय:
Original Basic Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351845/
https://ncbi.nlm.nih.gov/pubmed/25750589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-25
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन